MyMynd Secures £650,000 For Mental Health Intervention Platform
21 July 21
21 July 21
Triple Point Ventures is delighted to announce its participation in Quit Genius’ $64 million Series B funding led by Kinnevik AB, Atomico, Octopus Ventures, and others. Quit Genius plan to use the capital to help expand their reach in the U.S. and to continue investing in peer-reviewed studies that track and help improve its treatment programs.
Quit Genius is the world's first digital clinic delivering a comprehensive Medication-Assisted Treatment program for multiple addictions, 100% virtually.
Congratulations to Yusuf Sherwani, Maroof Ahmed MD, Sarim Siddiqui, and the rest of the Quit Genius team!
Read the announcement article
Find out more about Quit Genius
Triple Point Venture Fund VCT first invested in Quit Genius in 2020. To find out more about investing for your client visit here.
Risk Warning: The Triple Point Venture Fund VCT carries all the risks of investment in smaller companies and places investor’s capital at risk. Tax treatment depends on the individual circumstances of each client and is subject to change. Tax reliefs depend on the VCT maintaining its qualifying status.